Gary Sender - 15 May 2025 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Reporting relationship: Director
Issuer ticker: HRMY
Reported as of: 15 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 May 2025, 16:01:22 UTC
Prior SEC filing: 13 Jan 2025
Next SEC filing: 20 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Christian Ulrich, Attorney-in-Fact

Key filing fact

Gary Sender filed Form 4 for Harmony Biosciences Holdings, Inc. (HRMY) on 16 May 2025.

Key facts

This page summarizes Gary Sender's Form 4 filing for Harmony Biosciences Holdings, Inc. (HRMY).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 16 May 2025, 16:01.

Change

Previous filing in this sequence was filed on 13 Jan 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001659085 Primary reporting owner

Sender Gary

Relationship: Director
Address: C/O HARMONY BIOSCIENCES HOLDINGS, INC., 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING
Signature: /s/ Christian Ulrich, Attorney-in-Fact
Signature date: 16 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HRMY transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +14,522
Change %
Price: $0.000000
Shares after: 14,522
Date: 15 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 14,522
Exercise price: $34.23
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option shall vest in full on the earlier to occur of (i) May 15, 2026 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.